Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model

Recombinant activated factor VII attenuates major arterial bleeding in noncoagulopathic rabbits

(2010) Marion Durand et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Treatment of massive bleeding with prothrombin complex concentrate: argument against

(2010) A. GODIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

(2010) Elisabeth Perzborn et al.   NATURE REVIEWS DRUG DISCOVERY

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

(2010) Marcel Levi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assays for Measuring Rivaroxaban: Their Suitability and Limitations

(2010) Edelgard Lindhoff-Last et al.   THERAPEUTIC DRUG MONITORING

Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model

(2010) A. Godier et al.   THROMBOSIS AND HAEMOSTASIS

Rivaroxaban

(2009) Sean T. Duggan et al.   DRUGS

Rivaroxaban - an oral, direct Factor Xa inhibitor - lessons from a broad clinical study programme

(2009) Sylvia Haas   EUROPEAN JOURNAL OF HAEMATOLOGY

Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents

(2008) M. A. Crowther et al.   BLOOD

Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution

(2008) Mikhail V Ovanesov et al.   BLOOD COAGULATION & FIBRINOLYSIS

Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study

(2008) Y. DARGAUD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Reversal of the inhibitory effect of Fondaparinux on Thrombin generation by rFVIIa, aCCP and PCC

(2008) H. Desmurs-Clavel et al.   THROMBOSIS RESEARCH